The presently described studies test the hypothesis that p75NTR-induced potentiation of the effects of fenretinide on neuroblastoma cells occurs through regulation by p75NTR of the expression of the cellular retinoic acid binding protein I (CRABP1). This evidence concerns the gene NGFR and neuroblastoma.